Biopharma Co-promotion & Co-marketing Agreements Discussed by CurrentPartnering

14 May 2012 • by Natalie Aster

The majority of deals are multicomponent whereby the licensor retains either a right or option to co-promote/market the resultant product of the research collaboration. There are also numerous pure co-promotion/marketing deals whereby the products originator takes on a co-promotion/marketing partner in order to maximize a products presence in the marketplace.

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.

The new report “Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics” by CurrentPartnering provides details of the latest co-promotion and co-marketing agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully revised and updated, the report provides details of co-promotion and co-marketing agreements from 2007 to mid 2012.

Report Details:

Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
Published: May, 2012
Pages: 835
Price: US$ 2.695,00

This report contains a comprehensive listing of all co-promotion and co-marketing deals announced since 2007 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual co-promotion and co-marketing contract documents as submitted to the Securities Exchange Commission by companies and their partners.

Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.

More information can be found in the report “Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics” by CurrentPartnering.

To order the report or ask for sample pages contact [email protected]

Contacts

MarketPublishers, Ltd.
Tanya Rezler
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected]
MarketPublishers.com